← Master Registry

Published peptide research references

Voclosporin

Governed registry record

1 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

    DOI: 10.1016/s0140-6736(21)00578-x

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Rovin BH
  • Teng YKO
  • Ginzler EM
  • Arriens C
  • Caster DJ
  • Romero-Diaz J
  • Gibson K
  • Kaplan J
  • Lisk L
  • Navarra S
  • Parikh SV
  • Randhawa S
  • Solomons N
  • Huizinga RB
  • Siegel CH
  • Sammaritano LR
  • Hoi A
  • Igel T
  • Mok CC
  • Arnaud L
  • Fanouriakis A
  • Kostopoulou M
  • Andersen J
  • Aringer M
  • Bae SC
  • Boletis J
  • Bruce IN
  • Cervera R
  • Doria A
  • Dörner T
  • Furie RA
  • Gladman DD
  • Houssiau FA
  • Inês LS
  • Jayne D
  • Kouloumas M
  • Kovács L
  • Morand EF
  • Moroni G
  • Mosca M
  • Mucke J
  • Mukhtyar CB
  • Nagy G
  • Parodis I
  • Pego-Reigosa JM
  • Petri M
  • Pons-Estel BA
  • Schneider M
  • Smolen JS
  • Svenungsson E
  • Tanaka Y
  • Tektonidou MG
  • Teng YO
  • Tincani A
  • Vital EM
  • van Vollenhoven RF
  • Wincup C
  • Bertsias G
  • Boumpas DT